Trump administration signals international pricing index, importation rules are advancing

The Trump administration Wednesday published clues about pending proposed rules that would create a foreign reference pricing benchmark for Medicare Part B drug prices and allow importation of prescription drugs.

The White House Office of

Read the full 357 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE